Skip to main content

Table 1 Characterization of Nano-11-based vaccine formulations used in the study

From: A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs

  1. The table depicts the particle size (nm), PDI and Zeta potential (mV) of all the vaccine formulations used in the study
Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us